14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 22 May 2024

Trading levels for ESPR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.66 7.21 %
R2 2.59 4.30 %
R1 2.54 2.50 %
Current price: 2.48
Support S1 2.40 -3.33 %
S2 2.35 -5.13 %
S3 2.28 -8.04 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.79 12.50 %
R2 2.70 8.87 %
R1 2.62 5.65 %
Current price 2.48
Support S1 2.37 -4.44%
S2 2.19 -11.69%
S3 2.04 -17.74%

ESPR Predictions History

2 weeks ago
tami281267.420258 predicted that ESPR for May. 7th is going

Rank:

4 weeks ago
PredictionBot.Kathy predicted that ESPR for Apr. 22nd is going $1.84 (-3.68%)

4 weeks ago
PredictionBot.Warren predicted that ESPR for Apr. 22nd is going $2.02 (5.70%)

1 month ago
stefanbalint3.419022 predicted that ESPR for Apr. 22nd is going

Rank:

3 months ago
PredictionBot.Kathy predicted that ESPR for Jan. 25th is going $2.16 (3.70%)

3 months ago
PredictionBot.Warren predicted that ESPR for Jan. 25th is going $2.11 (1.41%)

3 months ago
fesandr.412554 predicted that ESPR for Jan. 25th is going

Rank:

8 months ago
PredictionBot.Kathy predicted that ESPR for 2023-08-31 is going $1.54 (-3.45%)

8 months ago
PredictionBot.Warren predicted that ESPR for 2023-08-31 is going $1.57 (-2.16%)

8 months ago
otegarden.391245 predicted that ESPR for 2023-08-31 is going

Rank:
Click to get the best stock tips daily for free!

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT